Current research investigates novel biomarkers that can predict therapeutic outcomes. Finding ways to determine therapeutic ...

AN ingredient found in cheap veg could help banish agonising period pain, scientists say. L-ergothioneine is an antioxidant – ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its global collaboration and licensing agreement with Astellas announced on February 23, 2026 has closed following expiration of the waiting ...

Innate immunity is a cornerstone of the body’s immediate defense against cancer, orchestrating the early recognition and response to tumor cells through key ...

Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...

PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will participate in RedChip’s upcoming ...

As the “Method of the Year 2024”, spatial proteomics (SP) enables in situ characterization of protein localization, abundance ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer.

Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...

Pancreatic cancer research tackles treatment resistance with targeted drug delivery, immune-boosting combinations, and ...

D Path will use its AI-enabled platform to analyze H&E-stained tumor biopsy slides and identify biomarkers of response to an undisclosed Daiichi ADC program.